ORPP logo

Gynaecological Oncology for the MRCOG and Beyond. (Record no. 88233)

MARC details
000 -LEADER
fixed length control field 11672nam a22005293i 4500
001 - CONTROL NUMBER
control field EBC3399999
003 - CONTROL NUMBER IDENTIFIER
control field MiAaPQ
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240729125442.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 240724s2011 xx o ||||0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781107710979
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781906985219
035 ## - SYSTEM CONTROL NUMBER
System control number (MiAaPQ)EBC3399999
035 ## - SYSTEM CONTROL NUMBER
System control number (Au-PeEL)EBL3399999
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)ebr10511564
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)923353380
040 ## - CATALOGING SOURCE
Original cataloging agency MiAaPQ
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency MiAaPQ
Modifying agency MiAaPQ
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC280.G5.G96 2010
082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.99465
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Acheson, Nigel.
245 10 - TITLE STATEMENT
Title Gynaecological Oncology for the MRCOG and Beyond.
250 ## - EDITION STATEMENT
Edition statement 2nd ed.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture London :
Name of producer, publisher, distributor, manufacturer Cambridge University Press,
Date of production, publication, distribution, manufacture, or copyright notice 2011.
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice ©2011.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (276 pages)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES STATEMENT
Series statement Membership of the Royal College of Obstetricians and Gynaecologists and Beyond Series
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Intro -- Title page -- Contents -- About the authors -- Preface -- Introduction to the second edition -- Abbreviations -- 1 Basic epidemiology -- Introduction -- Cervical cancer -- CERVICAL CANCER AND HUMAN PAPILLOMAVIRUS -- RISK FACTORS -- Oncogenes -- Genotype -- Smoking -- Hormonal contraception -- Dietary factors -- Endometrial cancer -- RISK FACTORS -- Obesity -- Polycystic ovary syndrome -- Parity -- Oral contraceptive pill -- Unopposed estrogen hormone replacement therapy -- Anti-estrogens -- Feminising ovarian tumours -- Diabetes and hypertension -- Endometrial hyperplasia -- Ovarian cancer -- RISK FACTORS -- Parity -- Genetic predisposition -- Oral contraceptive use -- Infertility -- Hormone replacement therapy -- Ovarian irritation -- Ovarian/peritoneal disease -- Smoking -- Squamous vulval cancer -- RISK FACTORS -- Squamous vulval intraepithelial neoplasia -- Lichen sclerosus -- Smoking -- KEY POINTS -- References -- 2 Basic pathology of gynaecological cancer -- Introduction -- Sending specimens to the laboratory -- FIXATION -- THE REQUEST FORM -- FROZEN SECTIONS -- Pathology of neoplasia and pre-neoplasia of the female genital tract -- CERVIX -- Cervical intraepithelial neoplasia -- Cervical glandular intraepithelial neoplasia -- Stratified mucinous intraepithelial lesion -- Invasive squamous carcinoma -- Invasive adenocarcinoma -- Adenosquamous carcinoma -- ENDOMETRIUM -- Endometrial carcinoma -- Endometrial hyperplasia -- Uterus -- MIXED TUMOURS OF THE UTERUS -- TUMOURS OF THE UTERINE WALL -- Endometrial stromal tumours -- Smooth muscle tumours of the uterus -- Ovary -- OVARIAN TUMOURS -- Borderline serous tumours -- Micropapillary serous carcinoma -- OVARIAN CARCINOMA -- Vulva -- VULVAL INTRAEPITHELIAL NEOPLASIA -- SQUAMOUS-CELL CARCINOMA -- VERRUCOUS CARCINOMA -- EXTRAMAMMARY PAGET'S DISEASE -- MELANOMA -- PERITONEAL PATHOLOGY.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Special studies in pathology -- HISTOCHEMISTRY -- IMMUNOHISTOCHEMISTRY AS A DIAGNOSTIC TOOL -- Extramammary Paget's disease -- Evaluating spindle tumours of the myometrium -- Glandular lesions of the cervix -- Peritoneal mesothelioma and serous carcinoma in the peritoneum -- PROGNOSTIC VALUE OF IMMUNOHISTOCHEMICAL MARKERS -- Tumour microstaging -- Markers to predict response to therapy -- Molecular pathology -- References -- 3 Preinvasive disease of the lower genital tract -- Introduction -- Preinvasive disease and terminology -- Human papillomaviruses -- DISEASE PREVENTION -- IMMORTALISATION AND TRANSFORMATION -- The NHS cervical screening programme -- RATES OF ABNORMALITY -- FURTHER INVESTIGATIONS -- THE COLPOSCOPIC EXAMINATION -- Glandular premalignancy of the cervix: adenocarcinoma in situ -- Vulval intraepithelial neoplasia -- Vaginal intraepithelial neoplasia -- References -- 4 Radiological assessment -- Introduction -- Ovarian cancer -- DIFFERENTIATING BENIGN FROM MALIGNANT OVARIAN MASSES -- PATIENTS WITH FEATURES IN KEEPING WITH MALIGNANCY AT ULTRASOUND -- MONITORING THERAPY AND RECURRENT DISEASE -- COMPLICATIONS -- Cervical cancer -- WHO SHOULD HAVE IMAGING? -- TUMOUR VOLUME -- Tumour confined to the cervix -- Parametrial extension -- CONFIRMING THAT THE TUMOUR IS CONFINED TO THECERVIX -- NODAL STATUS -- RADIOTHERAPY -- RECURRENT DISEASE AND COMPLICATIONS -- Endometrial cancer -- Rarer gynaecological tumours -- SARCOMAS -- GESTATIONAL TROPHOBLASTIC TUMOUR -- VAGINAL CANCER -- VULVAL CANCER -- References -- 5 Surgical principles -- Introduction -- Diagnosis -- Staging -- Treatment -- Reconstruction -- Palliation -- Complications of laparotomy -- Ovarian carcinoma -- PRIMARY SURGERY -- INTERVAL SURGERY -- SECOND-LOOK SURGERY -- SURGERY AT RELAPSE -- Cervical cancer -- COMPLICATIONS OF SURGICAL TREATMENT -- Endometrial cancer -- Vulval cancer.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note SURGERY IN RECURRENT OR ADVANCED DISEASE -- KEY POINTS -- References -- 6 Role of laparoscopic surgery -- Introduction -- Cervical cancer -- Endometrial cancer -- Ovarian cancer -- Surgical techniques -- RADICAL HYSTERECTOMY -- Technique -- PELVIC LYMPH NODE DISSECTION -- Technique -- LAPAROSCOPIC EXTRAPERITONEAL PARA-AORTIC NODE DISSECTION -- Technique -- KEY POINTS -- References -- 7 Radiotherapy: principles and applications -- Introduction -- Radiobiology -- Planning -- Implementation of brachytherapy -- IMPORTANCE OF RECTAL AND BLADDER DOSES -- DOSE PRESCRIPTION FOR RADIOTHERAPY INCARCINOMA OF THE CERVIX -- Adverse effects of radiotherapy -- Clinical applications of radiotherapy -- CERVICAL CANCER -- ENDOMETRIAL CANCER -- VULVAL CANCER -- VAGINAL CANCER -- OVARIAN CANCER -- RADIOTHERAPY FOR SYMPTOM CONTROL IN A PALLIATIVE CONTEXT -- KEY POINTS -- References -- 8 Chemotherapy: principles andapplications -- Introduction -- Treatment intent -- Toxicity -- Epithelial ovarian cancer -- EARLY-STAGE OVARIAN CANCER -- RECURRENT OVARIAN CANCER -- Cervical cancer -- Endometrial cancer -- Vulval cancer -- Rare tumours -- GESTATIONAL TROPHOBLASTIC TUMOURS -- NON-EPITHELIAL OVARIAN TUMOURS -- KEY POINTS -- References -- 9 Ovarian cancer standards of care -- Introduction -- Classification of ovarian cancer -- EPITHELIAL TUMOURS -- GRADE -- DISSEMINATION OF THE DISEASE -- PRIMARY PERITONEAL TUMOURS -- BORDERLINE TUMOURS -- NON-EPITHELIAL OVARIAN NEOPLASMS -- SEX-CORD STROMAL TUMOURS -- MALIGNANT GERM-CELL TUMOURS -- Prognostic factors -- Presentation and diagnosis -- INITIAL ASSESSMENT -- IF MALIGNANCY IS SUSPECTED -- Referral to the multidisciplinary team -- Surgery for ovarian carcinoma -- DIAGNOSIS -- STAGING -- PRIMARY CYTOREDUCTION -- OPTIMAL DEBULKING -- ULTRARADICAL SURGERY -- Lymphadenectomy -- CURRENT STANDARD.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Early stage disease, FIGO stage I and IIa epithelial ovarian cancer -- Stage IV disease -- CURRENT STANDARD -- Second-look laparotomy or laparoscopy -- CURRENT STANDARD -- Interval debulking surgery -- CURRENT STANDARD -- Neoadjuvant chemotherapy followed by surgery -- CURRENT STANDARD -- First line chemotherapy for epithelial ovarian cancer -- EARLY STAGE DISEASE -- Current standard -- ADVANCED DISEASE -- Current standard -- INTRAPERITONEAL CHEMOTHERAPY -- Current standard -- NOVEL CHEMOTHERAPEUTIC AND BIOLOGICAL AGENTS -- Management of relapsed disease -- THE ROLE OF CHEMOTHERAPY IN RECURRENT DISEASE -- Current practice -- NOVEL CHEMOTHERAPEUTIC AGENTS -- THE ROLE OF SURGERY IN RELAPSED DISEASE -- CURRENT PRACTICE -- Radiotherapy -- CURRENT PRACTICE -- Minimal access surgery -- CURRENT PRACTICE -- Response evaluation -- CURRENT STANDARD -- Follow-up -- Women with a family history -- CURRENT STANDARD -- Screening for ovarian carcinoma -- CURRENT STANDARD -- Reference List -- 10 Endometrial cancer standards of care -- Signs and symptoms -- Investigation -- Surgical management -- Radiotherapy and chemotherapy -- Palliative treatment and care -- Post-treatment support and follow-up -- Organisation and provision of services -- References -- 11 Cervical cancer standards of care -- Introduction -- Multidisciplinary team working -- CURRENT STANDARD -- Presentation -- CURRENT STANDARD -- Diagnosis and staging -- STAGING -- OTHER INVESTIGATIONS -- CURRENT STANDARD -- Treatment of cervical cancer -- STAGE IA -- Current standard -- STAGE IB AND IIA -- Current standard -- LOCALLY ADVANCED (STAGE IIB AND ABOVE) -- Current standard -- EXENTERATIVE SURGERY -- Current standard -- Post-treatment support and follow-up -- CURRENT STANDARD -- Management of recurrent disease -- CENTRAL PELVIC RELAPSE -- PELVIC SIDE WALL RECURRENCE -- CURRENT STANDARD.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note DISTANT METASTASES -- References -- 12 Vulval cancer standards of care -- Introduction -- CURRENT STANDARDS -- Prevention and predisposing conditions -- CURRENT STANDARD -- Referral from primary care -- CURRENT STANDARD -- Making the diagnosis -- FUNGATING OR ULCERATED MASS -- SMALL, WELL CIRCUMSCRIBED MASS -- A LESION UNEXPECTEDLY FOUND TO BE CANCEROUS -- Biopsy information -- HISTOLOGICAL SUBTYPES -- Current standard -- Planning treatment -- The importance of nodal status -- SENTINEL NODE SAMPLING -- Current standard -- Staging of vulval cancer -- Managing the primary lesion -- Managing the lymph nodes -- PELVIC NODES -- CURRENT STANDARDS -- Adjuvant radiotherapy: early disease -- INADEQUATE EXCISION MARGIN -- POSITIVE LYMPH NODES -- CURRENT STANDARD -- Advanced vulval cancer -- MANAGEMENT OF GROSSLY INVOLVED NODES -- COMBINED TREATMENT FOR THE PRIMARY -- Reconstructive surgery -- CURRENT STANDARD -- Morbidity -- POSTOPERATIVE MORBIDITY -- KEY POINTS -- References -- 13 Uncommon gynaecological cancers -- Introduction -- Gestational trophoblastic disease -- FIGO STAGING OF GESTATIONAL TROPHOBLASTIC TUMOURS -- RISK FACTORS -- PRESENTATION AND DIAGNOSIS -- INVESTIGATIONS -- MANAGEMENT -- FOLLOW-UP AND OUTCOME FOLLOWING CHEMOTHERAPY -- Cancer of the fallopian tube -- FIGO STAGING OF CARCINOMA OF THE FALLOPIAN TUBE -- PRESENTATION AND DIAGNOSIS -- INVESTIGATIONS -- MANAGEMENT -- Laparotomy -- Chemotherapy -- Radiation -- Tubal sarcomas -- Nonepithelial ovarian cancers -- OVARIAN GERM-CELL TUMOURS -- Presentation and diagnosis -- Investigations -- DYSGERMINOMAS -- Management -- Outcome -- IMMATURE TERATOMAS -- ENDODERMAL SINUS TUMOUR -- EMBRYONAL CARCINOMA -- POLYEMBRYOMA -- CHORIOCARCINOMA OF THE OVARY -- MIXED GERM-CELL TUMOURS -- OVARIAN SEX-CORD STROMAL CELL TUMOURS -- GRANULOSA-STROMAL CELL TUMOURS -- GRANULOSA-CELL TUMOURS -- Management.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note SERTOLI-LEYDIG TUMOURS.
520 ## - SUMMARY, ETC.
Summary, etc. Aimed at candidates for the MRCOG examination, this second edition includes chapters on the multidisciplinary approach to the care of women with gynaecological cancers. Additional chapters on laparoscopic surgery, basic surgical principles, palliative care, emergencies and complications are also featured. All content has been updated to reflect current practice.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on publisher supplied metadata and other sources.
590 ## - LOCAL NOTE (RLIN)
Local note Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Generative organs, Female -- Cancer.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Luesley, David.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Main entry heading Acheson, Nigel
Title Gynaecological Oncology for the MRCOG and Beyond
Place, publisher, and date of publication London : Cambridge University Press,c2011
International Standard Book Number 9781906985219
797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN)
Corporate name or jurisdiction name as entry element ProQuest (Firm)
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Membership of the Royal College of Obstetricians and Gynaecologists and Beyond Series
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3399999">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3399999</a>
Public note Click to View

No items available.

© 2024 Resource Centre. All rights reserved.